UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 280

Sortiert nach

The use of platelet-rich plasma gel in superficial parotidectomy

Acta otorhino-laryngologica italica, 2019-12, Vol.39 (6), p.363-366

2019

Volltextzugriff (PDF)

In-clinic secondary tracheoesophageal puncture and voice prosthesis placement in laryngectomees

European annals of otorhinolaryngology, head and neck diseases, 2018-10, Vol.135 (5), p.349-352

2018

Volltextzugriff (PDF)

Clinical significance of nonalbuminuric renal impairment in type 2 diabetes

Journal of hypertension, 2011-09, Vol.29 (9), p.1802-1809

2011

Volltextzugriff (PDF)

Concomitant Adjuvant Chemoradiotherapy with Weekly Low-dose Cisplatin for High-risk Squamous Cell Carcinoma of the Head and Neck: a Phase II Prospective Trial

Clinical oncology (Royal College of Radiologists (Great Britain)), 2011-03, Vol.23 (2), p.134-140

2011

Volltextzugriff (PDF)

HbA1c Variability as an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study

Diabetes care, 2013-08, Vol.36 (8), p.2301-2310

2013

Volltextzugriff (PDF)

Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study

Journal of internal medicine, 2021-07, Vol.290 (1), p.116-128

2021

Volltextzugriff (PDF)

Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naïve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY)

Acta diabetologica, 2022-10, Vol.59 (10), p.1317-1330

2022

Volltextzugriff (PDF)

Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study

Nutrition, metabolism, and cardiovascular diseases, 2024-08, Vol.34 (8), p.1846-1853

2024

Volltextzugriff (PDF)

Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study

Journal of internal medicine, 2013-08, Vol.274 (2), p.176-191

2013

Volltextzugriff (PDF)

Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care

Journal of endocrinological investigation, 2021-09, Vol.44 (9), p.1879-1889

2021

Volltextzugriff (PDF)

Pharyngocutaneous fistula as a complication of total laryngectomy: Review of the literature and analysis of case records

Otolaryngology-head and neck surgery, 2000-11, Vol.123 (5), p.587-592

2000

Volltextzugriff (PDF)

Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry

European journal of preventive cardiology, 2024-06, Vol.31 (8), p.1038

2024

Volltextzugriff (PDF)

Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins

Nutrition, metabolism, and cardiovascular diseases, 2022-09, Vol.32 (9), p.2255-2263

2022

Volltextzugriff (PDF)

Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study

Journal of endocrinological investigation, 2023-07, Vol.46 (7), p.1429-1439

2023

Volltextzugriff (PDF)

Similar effectiveness of dapagliflozin and GLP‐1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study

Diabetes, obesity & metabolism, 2019-08, Vol.21 (8), p.1886-1894

2019

Volltextzugriff (PDF)

Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study

BMC medicine, 2019-04, Vol.17 (1), p.83-83, Article 83

2019

Volltextzugriff (PDF)

Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity

Nutrition, metabolism, and cardiovascular diseases, 2017-12, Vol.27 (12), p.1089

2017

Volltextzugriff (PDF)

Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study

Journal of endocrinological investigation, 2020-03, Vol.43 (3), p.329-336

2020

Volltextzugriff (PDF)

Chronic kidney disease in type 2 diabetes: Lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study

Nutrition, metabolism, and cardiovascular diseases, 2014-08, Vol.24 (8), p.815-822

2014

Volltextzugriff (PDF)

The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy

Atherosclerosis, 2008-06, Vol.198 (2), p.396-402

2008

Volltextzugriff (PDF)

Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Advanced Head and Neck Squamous Cell Carcinoma

Anticancer research, 2008-03, Vol.28 (2B), p.1285-1291

2008

Volltextzugriff (PDF)

Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes

Cardiovascular diabetology, 2021-05, Vol.20 (1), p.103-103, Article 103

2021

Volltextzugriff (PDF)

Feasibility and effectiveness in clinical practice of a multifactorial intervention for the reduction of cardiovascular risk in patients with type 2 diabetes: the 2-year interim analysis of the MIND.IT study: a cluster randomized trial

Diabetes care, 2013-09, Vol.36 (9), p.2566-2572

2013

Volltextzugriff (PDF)

Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia

JAMA cardiology, 2024-04, Vol.9 (4), p.313

2024

Volltextzugriff (PDF)

Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk

The Lancet regional health. Europe, 2024-03, Vol.38, p.100847-100847, Article 100847

2024

Volltextzugriff (PDF)

1 – 25 von 280

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(199)
Science & Technology
(165)
Life Sciences & Biomedicine
(164)
Male
(140)
Female
(111)
Middle Aged
(85)
Adult
(82)
Biological And Medical Sciences
(80)
Endocrinology & Metabolism
(68)
Medical Sciences
(64)
Aged
(63)
Diabetes
(48)
Type 2 Diabetes
(47)
Cardiovascular System & Cardiology
(30)
Endocrinopathies
(29)
Endocrine Pancreas. Apud Cells
(28)
Diabetes. Impaired Glucose Tolerance
(25)
Otorhinolaryngology
(25)
Blood Platelets - Drug Effects
(23)
Diabetes Mellitus
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The use of platelet-rich plasma gel in superficial parotidectomy

In-clinic secondary tracheoesophageal puncture and voice prosthesis placement in laryngectomees

Clinical significance of nonalbuminuric renal impairment in type 2 diabetes

Concomitant Adjuvant Chemoradiotherapy with Weekly Low-dose Cisplatin for High-risk Squamous Cell Carcinoma of the Head and Neck: a Phase II Prospective Trial

HbA1c Variability as an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study

Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real‐life setting: the PROSISA Study

Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naïve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY)

Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study

Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study

Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care

Pharyngocutaneous fistula as a complication of total laryngectomy: Review of the literature and analysis of case records

Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry

Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins

Short-term effectiveness of dapagliflozin versus DPP-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study

Similar effectiveness of dapagliflozin and GLP‐1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study

Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study

Rationale and design of the DARWIN-T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes): A multicenter retrospective nationwide Italian study and crowdsourcing opportunity

Predictors of early discontinuation of dapagliflozin versus other glucose-lowering medications: a retrospective multicenter real-world study

Chronic kidney disease in type 2 diabetes: Lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study

The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy

Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Advanced Head and Neck Squamous Cell Carcinoma

Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes

Feasibility and effectiveness in clinical practice of a multifactorial intervention for the reduction of cardiovascular risk in patients with type 2 diabetes: the 2-year interim analysis of the MIND.IT study: a cluster randomized trial

Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia

Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk

Suchergebnisse filtern